IBD is a chronic inflammatory disease of the gastrointestinal tract, particularly small and large intestine consisting of ulcerative colitis (UC) and Crohn’s disease (CD). Oral route of drug delivery is considered as the most appropriate route of drug delivery of drugs. But this route has certain limitations of poor bioavailability due to gastric degradation and increase in dose size and frequency. Therefore, the present aim of the study is to prepare and evaluate Indomethacin loaded matrix tablet using guar gum, HPMC (release controlling polymer) and citric acid to facilitate the drug solubility in the colon. A total 8 different formulations were prepared by wet granulation method and coated with Eudragit S 100 polymer a pH dependent enteric coating polymer which dissolve at colonic pH (7.4) and specifically release the drug in the colon region in sustain release fashion. The granules evaluated for its micrometrics properties and tablets were evaluated for its hardness, thickness, friability, weight variation, drug content, and in-vitro drug release studies. The % cumulative drug release profile of all tablets was little and insignificant at pH 1.2 and 6.8. In colonic pH the coating dissolves tablets starts to release drugs. Among all the formulation the formulation F3 having guar gum and HPMC ratio 3:1 shows a maximum release of drug of 80.41±6.5%. At 24 h. The study demonstrated that the prepared tablets can release the Indomethacin in sustained release manner and helps in management of IBD with reduced side effect of the therapy. The results of this study show that oral administration of aspartame (250mg/kg body weight) was correlated to a significant increase in the lipid profile, fasting blood glucose and some marker enzymes and this increase is time related.
Cite this article:
Rohitas Deshmukh. Development and In‑Vitro Evaluation of Colon Specific Indomethacin Matrix Tablet for the Treatment of Inflammatory Bowel Disease. Research Journal of Pharmacy and Technology. 2021; 14(5):2391-6. doi: 10.52711/0974-360X.2021.00422
Rohitas Deshmukh. Development and In‑Vitro Evaluation of Colon Specific Indomethacin Matrix Tablet for the Treatment of Inflammatory Bowel Disease. Research Journal of Pharmacy and Technology. 2021; 14(5):2391-6. doi: 10.52711/0974-360X.2021.00422 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-5-6
1. Deshmukh R, Kumari S, Harwansh RK. Inflammatory Bowel Disease: A Snapshot of Current Knowledge. Research Journal of Pharmacy and Technology. 2020; 13(2): 956-62.
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002; 347(6): 417-29.
3. Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126(6): 1504-17.
4. Gupta A, Mittal A, Gupta AK. Colon targeted drug delivery systems–a review. Asian Journal of Pharmaceutical Research. 2011;1(2): 25-33.
5. Hanić M, Trbojević-Akmačić I, Lauc G. Inflammatory bowel disease-glycomics perspective. Biochimica et Biophysica Acta (BBA)-General Subjects. 2019.
6. Koliani-Pace JL, Siegel CA. Prognosticating the Course of Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics. 2019;29(3): 395-404.
7. Agrawal M, Colombel J-F. Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat? Gastrointestinal Endoscopy Clinics. 2019;29(3): 421-36.
8. Farheen F, Elango K, Devi DR, Santhanalakshmi G. Formulation and Evaluation of Controlled Porosity Prednisolone Osmotic tablets for Colon Targeting. Research Journal of Pharmacy and Technology. 2011;4(7): 1106-10.
9. Dhole AR, Shendage GG, Pethkar S, Magdum C, Mohite S. Drug used in inflammatory bowel disease (IBD)-Brief review. Research Journal of Pharmacology and Pharmacodynamics. 2014;6(3): 153-61.
10. Mehta R, Chawla A, Sharma P, Pawar P. Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system. Journal of Advanced Pharmaceutical Technology & Research. 2013;4(1): 31.
11. Songire PR, Aher SS, Saudagar R. Recent research on matrix tablets for controlled release-a review. Asian Journal of Pharmacy and Technology. 2015;5(4): 214-21.
12. Anande NM, Jain SK, Jain NK. Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoate. International Journal of Pharmaceutics. 2008;359(1-2): 182-9.
13. Ren Y, Jiang L, Yang S, Gao S, Yu H, Hu J, et al. Design and preparation of a novel colon-targeted tablet of hydrocortisone. Brazilian Journal of Pharmaceutical Sciences. 2016;52(2): 239-50.
14. Chen J, Li X, Chen L, Xie F. Starch film-coated microparticles for oral colon-specific drug delivery. Carbohydrate Polymers. 2018;191: 242-54.
15. Song R, Murphy M, Li C, Ting K, Soo C, Zheng Z. Current development of biodegradable polymeric materials for biomedical applications. Drug Design, Development and Therapy. 2018;12: 3117-45.
16. Sinha VR, Kumria R. Polysaccharides in colon-specific drug delivery. International Journal of Pharmaceutics. 2001;224(1-2): 19-38.
17. Hingmire L, Deshmukh V, Sakarkar D. Development and Evaluation of Sustained Release Matrix Tablets Using Natural Polymer as Release Modifier. Research Journal of Pharmacy and Technology. 2008;1(3): 193-6.
18. Rajpurohit H, Sharma P, Sharma S, Bhandari A. Polymers for colon targeted drug delivery. Indian Journal of Pharmaceutical Sciences. 2010;72(6): 689-96.
19. Chourasia MK, Jain SK. Polysaccharides for colon targeted drug delivery. Drug Deliv. 2004;11(2): 129-48.
20. Deshmukh R, Harwansh RK, Paul SD, Shukla R. Controlled release of sulfasalazine loaded amidated pectin microparticles through Eudragit S 100 coated capsule for management of inflammatory bowel disease. Journal of Drug Delivery Science and Technology. 2020;55: 101495.
21. Sridhar G, Sivaneswari S, Preethi N, Mounika B, Hemalatha G, Murthy SV. Influence of natural gums as sustain release carriers on release kinetics of valsartan matrix tablets. Research Journal of Pharmaceutical Dosage Forms and Technology. 2014;6(3): 188-93.
22. Mudgil D, Barak S, Khatkar BS. Guar gum: processing, properties and food applications-A Review. Journal of Food Science and Technology. 2014;51(3): 409-18.
23. George A, Shah PA, Shrivastav PS. Guar gum: Versatile natural polymer for drug delivery applications. European Polymer Journal. 2019;112: 722-35.
24. Ganesan V, Jayachandran D. Design and evaluation of matrix tablets of ambroxol hydrochloride using guargum. Research Journal of Pharmacy and Technology. 2008;1(4): 507-12.
25. Bacchi S, Palumbo P, Sponta A, Coppolino M. Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents). 2012;11(1): 52-64.
26. Elkhodairy KA, Elsaghir HA, Al-Subayiel AM. Formulation of indomethacin colon targeted delivery systems using polysaccharides as carriers by applying liquisolid technique. BioMed Research International. 2014; 2014.
27. Higuchi K, Umegaki E, Watanabe T, Yoda Y, Morita E, Murano M, et al. Present status and strategy of NSAIDs-induced small bowel injury. Journal of Gastroenterology. 2009;44(9): 879-88.
28. Maharjan S, Prajapati N, Shrestha A. Formulation and Evaluation of sustained release Sodium Alginate beads of Indomethacin. Asian Journal of Pharmacy and Technology. 2019;9(3): 165-72.
29. Sulthana A, Ramu B, Srikanth G, Rajkamal B. Formulation and evaluation of colon specific tinidazole matrix tablets. Research Journal of Pharmaceutical Dosage Forms and Technology. 2016;8(3): 167-72.
30. Pawar PK, Gautam C. Design, optimization and evaluation of mesalamine matrix tablet for colon drug delivery system. Journal of Pharmaceutical Investigation. 2016;46(1): 67-78.